In particular, phloretin was found to activate the Nrf2 pathway in the brain upon cerebral ischemia and decrease amyloid beta accumulation in the rat Alzheimer’s disease model [80–84]. The gene discussed is NFE2L2; the disease is early-onset autosomal dominant Alzheimer disease.